Formed as a special purpose acquisition company, the entity was created to raise capital through a public listing and merge with a private business in the life sciences sector. The vehicle was sponsored by investment firms with a focus on biotechnology and healthcare innovation, aiming to take a tar...
1 member of Congress has disclosed 1 trade in CM Life Sciences III Inc. (CMLTU), a Financial Services company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-04-09 | Tom Malinowski | buy | $15K – $50K |